Stockreport

Lake Street Raises Evaxion (EVAX) PT to $11 Following Positive Two-Year EVX-01 Melanoma Data [Yahoo! Finance]

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF 20, Lake Street analyst Thomas Flaten raised the firm's price target on Evaxion Biotech to $11 from $6 and kept a Buy rating on the shares. This sentiment was announced [Read more]